Cutler Group LP Soleno Therapeutics Inc Call Options Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Oct 27, 2020
SELL
$1.71 - $2.51 $282,150 - $414,149
-165,000 Reduced 99.94%
100 $0
Q2 2020

Jul 22, 2020
BUY
$1.77 - $4.23 $292,227 - $698,373
165,100 New
165,100 $5,000

About SOLENO THERAPEUTICS INC

SLNO Quotes by TradingView
  • Ticker SLNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,101,250
  • Market Cap $375M
  • Description
  • Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...
More about SLNO
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email